Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.500 |
None |
1.000 |
3 |
|
2006 |
2012 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.400 |
None |
1.000 |
2 |
1
|
2013 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.340 |
None |
1.000 |
5 |
|
1999 |
2018 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.320 |
None |
1.000 |
3 |
|
2004 |
2015 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.320 |
None |
1.000 |
3 |
|
2004 |
2015 |
Hepatitis
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
656
|
42
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Thyroid Gland Follicular Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
202
|
14
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Injury of liver
|
disease |
Digestive System Diseases; Wounds and Injuries
|
Injury or Poisoning
|
36
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cadmium poisoning
|
disease |
Chemically-Induced Disorders
|
Injury or Poisoning
|
8
|
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.050 |
None |
1.000 |
5 |
|
2005 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2001 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2017 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2017 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2016 |
Hepatitis C, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
430
|
80
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2017 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.020 |
None |
0.500 |
2 |
|
2007 |
2018 |